|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Cash Flows From Operating Activities | ||
| Net Income (Loss) | ||
| Adjustments: | ||
| Depreciation and Amortization | ||
| Reversal of Allowance for Credit Loss on Accounts Receivable | ||
| Property and Equipment Written Off | ||
| Gain on Derecognition of Operating Lease Right-of-Use Asset | ||
| Interest Expense – Deferred Consideration | ||
| Allowance for Expected Credit Loss on Accounts Receivable | ||
| Unrealised Foreign Exchange (Gain) / Loss | ||
| Changes in Operating Assets and Liabilities: | ||
| Accounts Receivable | ||
| Prepaid Expenses and Other Current Assets | ||
| Accounts Payable | ||
| Accruals and Other Current Liabilities | ||
| Operating Lease Right-of-Use Assets and Lease Liabilities, net | ||
| Income Tax Payable | ||
| Net Cash (Used in) Provided by Operating Activities | ||
| Cash Flows From Investing Activities | ||
| Purchases of Plant and Equipment | ||
| Cash paid for Business Acquisitions, Net of Cash Acquired | ||
| Net Cash Used in Investing Activities | ||
| Cash Flows From Financing Activities | ||
| Dividend Paid | ||
| Repayment to a Director | ||
| Deferred IPO costs | ||
| Repurchase of Treasury Shares | ||
| Proceeds from Issuance of Ordinary Shares | ||
| Net Cash (Used in) Provided by Financing Activities | ||
| Net Change in Cash and Cash Equivalents | ||
| Cash and Cash Equivalents as of Beginning of the Year | ||
| Effects on Currency Translation on Cash and Cash Equivalents | ||
| Cash and Cash Equivalents as of the End of the Year | ||
| Supplementary Cash Flows Information | ||
| Cash Paid for Taxes |
Loading...
